Milestone invests $30 million in Chinese pharma group
Milestone Capital, a Shanghai-based private equity firm, has reached an agreement to invest $30 million in China BCT Pharmacy Group, Inc., a listed pharmaceutical distributor, retail pharmacy, and manufacturer of pharmaceutical products in Guangxi Province, China.
According to a company press release, the preferred shares carry a dividend of 5% and are convertible initially into an equal number of shares in China BCT Pharmacy's Common Stock at an initial conversion...
More on Greater China
Latest News
Asian GPs slow implementation of ESG policies - survey
Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...
Singapore fintech start-up LXA gets $10m seed round
New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.
India's InCred announces $60m round, claims unicorn status
Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”
Insight leads $50m round for Australia's Roller
Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.